Celsense

CytoAgents, Inc is a Pittsburgh-based biotechnology company that is dedicated to developing innovative treatments for Cytokine Release Syndrome (CRS), a potentially life-threatening immune system overreaction. Their lead therapy, CTO1681, is an orally bioavailable immunomodulator that safely downregulates the production of CRS-inducing cytokines, effectively stopping CRS and rebalancing the body's immune response. With a highly specific mechanism of action and demonstrated efficacy in multiple models, CytoAgents is currently conducting a Phase 1b/2a clinical trial to treat CRS in patients receiving CAR T-cell therapy. Their goal is to provide a safe and effective treatment for CRS, improving patient outcomes and expanding access to important new treatment modalities in oncology and other therapeutic areas.Generated from the website

Furanica, Inc is a Pittsburgh-based company specializing in innovative technology solutions for various industries. With a focus on research and development, Furanica, Inc offers cutting-edge products and services to meet the evolving needs of its clients. Generated from their business information

Unipack Inc, located in Pittsburgh, PA, is a leading manufacturer of over-the-counter medications, adhering to Good Manufacturing Practices (cGMP) and Food and Drug Administration (FDA) compliance. The company's Development Team possesses extensive knowledge and experience, enabling them to bring personal products and topical medications from concept to commercialization while maintaining affordability for consumers. With an FDA-registered and cGMP-compliant facility, Unipack Inc produces a wide range of products, including suppositories, topical creams, and ointments, for national and international pharmacies and retailers. The company also offers contract packaging services and private label options, establishing direct selling relationships with major domestic retailers to ensure high service levels. Generated from the website